Home/Filings/4/0001209191-21-013258
4//SEC Filing

Elvig Mark F 4

Accession 0001209191-21-013258

CIK 0001000229other

Filed

Feb 22, 7:00 PM ET

Accepted

Feb 23, 4:53 PM ET

Size

5.7 KB

Accession

0001209191-21-013258

Insider Transaction Report

Form 4
Period: 2021-02-19
Elvig Mark F
VP, Counsel & Secretary
Transactions
  • Award

    Performance Shares

    2021-02-19+6,9006,900 total
    Exercise: $0.00Common Shares (6,900 underlying)
Footnotes (1)
  • [F1]This award vests at the end of a three-year performance period that begins on January 1, 2021 and ends on December 31, 2023 (the "Performance Period"). This award survives termination of employment due to death, disability, termination by the Company without cause or retirement by the employee upon having reached 62 years of age. At the end of the Performance Period, 100% of the award will vest if the Company is in the top 75th percentile of Return on Invested Capital of the Bloomberg Peer Group, as measured and determined by the Compensation Committee at the end of the Performance Period.

Issuer

CORE LABORATORIES N V

CIK 0001000229

Entity typeother

Related Parties

1
  • filerCIK 0001435153

Filing Metadata

Form type
4
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 4:53 PM ET
Size
5.7 KB